Drug Trial Radar · NCT00247273
A Study of Monthly Risedronate for Osteoporosis
Last checked: Nov 20, 2026Latest source record: Apr 22, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,294
Actual
Start
Oct 2005
Primary completion
Mar 2008
Study completion Apr 2008
Sponsor
- Lead sponsor
- Warner ChilcottIndustry
- Sponsor type
- Industry
- Collaborators
- Sanofi
- First posted
- Nov 1, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- Female only, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this trial is to study the efficacy of a single-dose monthly dosing regimen as compared to the standard daily dosing regimen of risedronate 5 mg daily.
Conditions
- Postmenopausal Osteoporosis
Interventions
risedronateDrug
tablet, 5 mg risedronate, once a day for 2 years
risedronateDrug
oral, 150 mg risedronate, once a month for 2 years
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline in Lumbar Spine Bone Mineral Density (BMD) at Month 12-Endpoint in Women With Postmenopausal Osteoporosis, Primary Efficacy PopulationTime frame: Baseline to Month 12 - Endpoint
Locations
49 sites in 14 countries. Site status is shown where the registry gives one.
Research Site
Lakewood, Colorado
Research Site
Gainesville, Georgia
Research Site
Bethesda, Maryland
Research Site
Omaha, Nebraska
Research Site
West Haverstraw, New York
Research Site
Cincinnati, Ohio
Research Site
Portland, Oregon
Research Site
Capital Federal, Argentina
Research Site
Buenos Aires, Buenos Aires, Argentina
Research Site
Geelong, Australia
Research Site
Heidelberg, Victoria, Australia
Research Site
Saint Leonards, Australia
Research Site
Brussels, Belgium
Research Site
Ghent, Belgium
Research Site
Leuven, Belgium
Research Site
Liège, Belgium
Research Site
Mont Godinne, Belgium
Research Site
Rio de Janeiro, Brazil
Research Site
São Paulo, Brazil
Research Site
Calgary, Canada
Research Site
Montreal, Canada
Research Site
Sainte-Foy, Canada
Research Site
Saskatoon, Canada
Research Site
Pärnu, Estonia
Research Site
Tartu, Estonia
Research Site
Helsinki, Finland
Research Site
Kuopio, Finland
Research Site
Oulu, Finland
Research Site
Turku, Finland
Research Site
Amiens, France
Research Site
Lyon, France
Research Site
Orléans, France
Research Site
Paris, France
Research Site
Toulouse, France
Research Site
Vandœuvre-lès-Nancy, France
Research Site
Balatonfüred, Hungary
Research Site
Budapest, Hungary
Research Site
Győr, Hungary
Research Site
Miskolc, Hungary
Research Site
Nagykanizs, Hungary
Showing 40 of 49 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.